Enhanced active case finding of drug-resistant tuberculosis in Namibia: a protocol for the hotspots, hospitals, and households (H3TB) study.

Feb 12, 2024

Experts: Olga Shavuka, Etuhole Iipumbu, Lorraine Boois, Gunar Günther, Graeme Hoddinott, Hsien-Ho Lin, Emmanuel Nepolo, Stefan Niemann, Nunurai Ruswa, James Seddon, Mareli M Claassens

Namibia is a high tuberculosis (TB)-burden country with an estimated incidence of 460/100 000 (around 12 000 cases) per year. Approximately 4.5% of new cases and 7.9% of previously treated TB cases are multidrug resistant (MDR) and 47% of patients with MDR-TB are HIV coinfected. Published data suggest a clustering of MDR-TB transmission in specific areas. Identifying transmission clusters is key to implementing high-yield and cost-effective interventions. This includes knowing the yield of finding TB cases in high-transmission zones (eg, community hotspots, hospitals or households) to deliver community-based interventions. We aim to identify such transmission zones for enhanced case finding and evaluate the effectiveness of this approach.
H3TB is an observational cross-sectional study evaluating MDR-TB active case finding strategies. Sputum samples from MDR-TB cases in three regions of Namibia will be evaluated by whole genome sequencing (WGS) in addition to routine sputum investigations (Xpert MTB/RIF, culture and drug susceptibility testing). We will collect information on household contacts, use of community spaces and geographical map intersections between participants, synthesising these data to identify transmission hotspots. We will look at the feasibility, acceptability, yield and cost of case finding strategies in these hotspots, and in households of patients with MDR-TB and visitors of hospitalised patients with MDR-TB. A compartmental transmission dynamic model will be constructed to evaluate the impact and cost-effectiveness of the strategies if scaled.
Ethics approval was obtained. Participants will give informed consent. H3TB will capitalise on a partnership with the Ministry of Health and Social Services to follow up individuals diagnosed with MDR-TB and integrate WGS data with innovative contact network mapping, to allow enhanced case finding. Study data will contribute towards a systems approach to TB control. Equally important, it will serve as a role model for similar studies in other high-incidence settings.

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.

Author

admin

View all posts

ABOUT THE EXPERTS

Olga Shavuka, Etuhole Iipumbu, Lorraine Boois, Gunar Günther, Graeme Hoddinott, Hsien-Ho Lin, Emmanuel Nepolo, Stefan Niemann, Nunurai Ruswa, James Seddon, Mareli M Claassens

Olga Shavuka

Department of Human Biological and Translational Medical Sciences, University of Namibia, Windhoek, Khomas, Namibia.

Etuhole Iipumbu

Department of Human Biological and Translational Medical Sciences, University of Namibia, Windhoek, Khomas, Namibia.

Lorraine Boois

Department of Human Biological and Translational Medical Sciences, University of Namibia, Windhoek, Khomas, Namibia.

Gunar Günther

Department of Human Biological and Translational Medical Sciences, University of Namibia, Windhoek, Khomas, Namibia.

Inselspital, University of Bern, Bern, Switzerland.

Graeme Hoddinott

Desmond Tutu TB Centre, Department of Pediatrics and Child Health, Stellenbosch University Faculty of Medicine and Health Sciences, Cape Town, Western Cape, South Africa.

Hsien-Ho Lin

National Taiwan University, Taipei, Taiwan.

Emmanuel Nepolo

Department of Human Biological and Translational Medical Sciences, University of Namibia, Windhoek, Khomas, Namibia.

Stefan Niemann

Department of Human Biological and Translational Medical Sciences, University of Namibia, Windhoek, Khomas, Namibia.

Molecular and Experimental Mycobacteriology Group, Forschungszentrum Borstel, Borstel, Germany.

Nunurai Ruswa

National Tuberculosis and Leprosy Programme (NTLP), Windhoek, Namibia.

James Seddon

Desmond Tutu TB Centre, Department of Pediatrics and Child Health, Stellenbosch University Faculty of Medicine and Health Sciences, Cape Town, Western Cape, South Africa.

Department of Infectious Disease, Imperial College London, London, UK.

Mareli M Claassens

Department of Human Biological and Translational Medical Sciences, University of Namibia, Windhoek, Khomas, Namibia mcla@sun.ac.za.

Desmond Tutu TB Centre, Department of Pediatrics and Child Health, Stellenbosch University Faculty of Medicine and Health Sciences, Cape Town, Western Cape, South Africa.